New “Accord Cadre” finally released by the CEPS in France
Published on January 19, 2023
The Accord Cadre is the framework agreement signed between the industry association of French pharmaceutical manufacturers (LEEM) and the CEPS (French pricing committee) that defines pricing regulation for both hospital and retail drugs. The agreement serves as a charter for pricing negotiations and is critical for ensuring transparency and consistency for the industry. The prior agreement was signed in December 2015 and was set to expire in December 2018, but was subsequently extended multiple times until a revised agreement could be negotiated. The new Accord Cadre, released in March, is organized into 5 chapters and 35 articles. It is similar to its predecessor, but with some important changes:
